Helicobacter	B:C0079488
pylori	I:C0079488
prevalence	O
and	O
clinical	O
significance	I:C2826293
in	O
patients	O
with	O
quiescent	O
Crohn	O
's	O
disease	O
.	O

Helicobacter	O
pylori	I:C0079488
prevalence	O
and	O
clinical	B:C2826293
significance	I:C2826293
in	O
patients	O
with	O
quiescent	O
Crohn	O
's	O
disease	O
.	O

Helicobacter	B:C0079487
pylori	I:C0079487
(	I:C0079487
HP	I:C0079487
)	I:C0079487
infection	I:C0079487
is	O
present	O
in	O
about	O
50	O
%	O
of	O
the	O
global	O
population	I:C1257890
,	O
and	O
is	O
associated	O
with	O
chronic	O
gastritis	I:C0085695
,	O
peptic	O
disease	I:C0030920
and	O
gastric	O
malignancies	I:C0024623
.	O

Helicobacter	O
pylori	I:C0079487
(	I:C0079487
HP	I:C0079487
)	I:C0079487
infection	I:C0079487
is	O
present	O
in	O
about	O
50	O
%	O
of	O
the	O
global	B:C1257890
population	I:C1257890
,	O
and	O
is	O
associated	O
with	O
chronic	O
gastritis	I:C0085695
,	O
peptic	O
disease	I:C0030920
and	O
gastric	O
malignancies	I:C0024623
.	O

Helicobacter	O
pylori	I:C0079487
(	I:C0079487
HP	I:C0079487
)	I:C0079487
infection	I:C0079487
is	O
present	O
in	O
about	O
50	O
%	O
of	O
the	O
global	O
population	I:C1257890
,	O
and	O
is	O
associated	O
with	O
chronic	B:C0085695
gastritis	I:C0085695
,	O
peptic	O
disease	I:C0030920
and	O
gastric	O
malignancies	I:C0024623
.	O

Helicobacter	O
pylori	I:C0079487
(	I:C0079487
HP	I:C0079487
)	I:C0079487
infection	I:C0079487
is	O
present	O
in	O
about	O
50	O
%	O
of	O
the	O
global	O
population	I:C1257890
,	O
and	O
is	O
associated	O
with	O
chronic	O
gastritis	I:C0085695
,	O
peptic	B:C0030920
disease	I:C0030920
and	O
gastric	O
malignancies	I:C0024623
.	O

Helicobacter	O
pylori	I:C0079487
(	I:C0079487
HP	I:C0079487
)	I:C0079487
infection	I:C0079487
is	O
present	O
in	O
about	O
50	O
%	O
of	O
the	O
global	O
population	I:C1257890
,	O
and	O
is	O
associated	O
with	O
chronic	O
gastritis	I:C0085695
,	O
peptic	O
disease	I:C0030920
and	O
gastric	B:C0024623
malignancies	I:C0024623
.	O

Helicobacter	B:C0079488
pylori	I:C0079488
prevalence	O
in	O
Crohn	O
's	I:C0010346
disease	I:C0010346
(	O
Crohn	O
's	I:C0010346
disease	I:C0010346
)	O
patients	O
was	O
shown	O
to	O
be	O
low	O
compared	O
to	O
the	O
general	O
population	O
,	O
and	O
its	O
influence	O
on	O
disease	O
activity	O
is	O
yet	O
to	O
be	O
determined	O
.	O

Helicobacter	O
pylori	I:C0079488
prevalence	O
in	O
Crohn	B:C0010346
's	I:C0010346
disease	I:C0010346
(	O
Crohn	O
's	I:C0010346
disease	I:C0010346
)	O
patients	O
was	O
shown	O
to	O
be	O
low	O
compared	O
to	O
the	O
general	O
population	O
,	O
and	O
its	O
influence	O
on	O
disease	O
activity	O
is	O
yet	O
to	O
be	O
determined	O
.	O

Helicobacter	O
pylori	I:C0079488
prevalence	O
in	O
Crohn	O
's	I:C0010346
disease	I:C0010346
(	O
Crohn	B:C0010346
's	I:C0010346
disease	I:C0010346
)	O
patients	O
was	O
shown	O
to	O
be	O
low	O
compared	O
to	O
the	O
general	O
population	O
,	O
and	O
its	O
influence	O
on	O
disease	O
activity	O
is	O
yet	O
to	O
be	O
determined	O
.	O

Helicobacter	O
pylori	I:C0079488
prevalence	O
in	O
Crohn	O
's	I:C0010346
disease	I:C0010346
(	O
Crohn	O
's	I:C0010346
disease	I:C0010346
)	O
patients	O
was	O
shown	O
to	O
be	O
low	O
compared	O
to	O
the	O
general	O
population	B:C1257890
,	O
and	O
its	O
influence	O
on	O
disease	O
activity	O
is	O
yet	O
to	O
be	O
determined	O
.	O

Our	O
aims	O
were	O
to	O
determine	O
the	O
prevalence	O
of	O
Helicobacter	B:C0079488
pylori	I:C0079488
in	O
a	O
selected	O
group	O
of	O
Crohn	O
's	I:C0010346
disease	I:C0010346
patients	O
with	O
quiescent	O
disease	O
,	O
and	O
to	O
assess	O
the	O
influence	O
of	O
its	O
eradication	O
on	O
disease	O
activity	O
and	O
endoscopic	O
and	O
laboratory	O
activity	I:C0022885
measures	I:C0022885
.	O

Our	O
aims	O
were	O
to	O
determine	O
the	O
prevalence	O
of	O
Helicobacter	O
pylori	I:C0079488
in	O
a	O
selected	O
group	O
of	O
Crohn	B:C0010346
's	I:C0010346
disease	I:C0010346
patients	O
with	O
quiescent	O
disease	O
,	O
and	O
to	O
assess	O
the	O
influence	O
of	O
its	O
eradication	O
on	O
disease	O
activity	O
and	O
endoscopic	O
and	O
laboratory	O
activity	I:C0022885
measures	I:C0022885
.	O

Our	O
aims	O
were	O
to	O
determine	O
the	O
prevalence	O
of	O
Helicobacter	O
pylori	I:C0079488
in	O
a	O
selected	O
group	O
of	O
Crohn	O
's	I:C0010346
disease	I:C0010346
patients	O
with	O
quiescent	O
disease	O
,	O
and	O
to	O
assess	O
the	O
influence	O
of	O
its	O
eradication	B:C3178994
on	O
disease	O
activity	O
and	O
endoscopic	O
and	O
laboratory	O
activity	I:C0022885
measures	I:C0022885
.	O

Our	O
aims	O
were	O
to	O
determine	O
the	O
prevalence	O
of	O
Helicobacter	O
pylori	I:C0079488
in	O
a	O
selected	O
group	O
of	O
Crohn	O
's	I:C0010346
disease	I:C0010346
patients	O
with	O
quiescent	O
disease	O
,	O
and	O
to	O
assess	O
the	O
influence	O
of	O
its	O
eradication	O
on	O
disease	O
activity	O
and	O
endoscopic	B:C0014245
and	O
laboratory	O
activity	I:C0022885
measures	I:C0022885
.	O

Our	O
aims	O
were	O
to	O
determine	O
the	O
prevalence	O
of	O
Helicobacter	O
pylori	I:C0079488
in	O
a	O
selected	O
group	O
of	O
Crohn	O
's	I:C0010346
disease	I:C0010346
patients	O
with	O
quiescent	O
disease	O
,	O
and	O
to	O
assess	O
the	O
influence	O
of	O
its	O
eradication	O
on	O
disease	O
activity	O
and	O
endoscopic	O
and	O
laboratory	B:C0022885
activity	I:C0022885
measures	I:C0022885
.	O

Consecutive	O
Crohn	B:C0010346
's	I:C0010346
disease	I:C0010346
patients	O
with	O
quiescent	O
disease	O
underwent	O
meticulous	O
disease	I:C0012634
evaluation	O
with	O
MR	O
enterography	I:C4274338
(	O
MR	O
enterography	I:C4274338
)	O
,	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
(	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
)	O
,	O
CRP	O
,	O
fecal	O
calprotectin	I:C1964053
and	O
CDAI	O
.	O

Consecutive	O
Crohn	O
's	I:C0010346
disease	I:C0010346
patients	O
with	O
quiescent	O
disease	O
underwent	O
meticulous	B:C0012634
disease	I:C0012634
evaluation	O
with	O
MR	O
enterography	I:C4274338
(	O
MR	O
enterography	I:C4274338
)	O
,	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
(	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
)	O
,	O
CRP	O
,	O
fecal	O
calprotectin	I:C1964053
and	O
CDAI	O
.	O

Consecutive	O
Crohn	O
's	I:C0010346
disease	I:C0010346
patients	O
with	O
quiescent	O
disease	O
underwent	O
meticulous	O
disease	I:C0012634
evaluation	B:C0220825
with	O
MR	O
enterography	I:C4274338
(	O
MR	O
enterography	I:C4274338
)	O
,	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
(	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
)	O
,	O
CRP	O
,	O
fecal	O
calprotectin	I:C1964053
and	O
CDAI	O
.	O

Consecutive	O
Crohn	O
's	I:C0010346
disease	I:C0010346
patients	O
with	O
quiescent	O
disease	O
underwent	O
meticulous	O
disease	I:C0012634
evaluation	O
with	O
MR	B:C4274338
enterography	I:C4274338
(	O
MR	O
enterography	I:C4274338
)	O
,	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
(	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
)	O
,	O
CRP	O
,	O
fecal	O
calprotectin	I:C1964053
and	O
CDAI	O
.	O

Consecutive	O
Crohn	O
's	I:C0010346
disease	I:C0010346
patients	O
with	O
quiescent	O
disease	O
underwent	O
meticulous	O
disease	I:C0012634
evaluation	O
with	O
MR	O
enterography	I:C4274338
(	O
MR	B:C4274338
enterography	I:C4274338
)	O
,	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
(	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
)	O
,	O
CRP	O
,	O
fecal	O
calprotectin	I:C1964053
and	O
CDAI	O
.	O

Consecutive	O
Crohn	O
's	I:C0010346
disease	I:C0010346
patients	O
with	O
quiescent	O
disease	O
underwent	O
meticulous	O
disease	I:C0012634
evaluation	O
with	O
MR	O
enterography	I:C4274338
(	O
MR	O
enterography	I:C4274338
)	O
,	O
video	B:C1721048
capsule	I:C1721048
endoscopy	I:C1721048
(	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
)	O
,	O
CRP	O
,	O
fecal	O
calprotectin	I:C1964053
and	O
CDAI	O
.	O

Consecutive	O
Crohn	O
's	I:C0010346
disease	I:C0010346
patients	O
with	O
quiescent	O
disease	O
underwent	O
meticulous	O
disease	I:C0012634
evaluation	O
with	O
MR	O
enterography	I:C4274338
(	O
MR	O
enterography	I:C4274338
)	O
,	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
(	O
video	B:C1721048
capsule	I:C1721048
endoscopy	I:C1721048
)	O
,	O
CRP	O
,	O
fecal	O
calprotectin	I:C1964053
and	O
CDAI	O
.	O

Consecutive	O
Crohn	O
's	I:C0010346
disease	I:C0010346
patients	O
with	O
quiescent	O
disease	O
underwent	O
meticulous	O
disease	I:C0012634
evaluation	O
with	O
MR	O
enterography	I:C4274338
(	O
MR	O
enterography	I:C4274338
)	O
,	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
(	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
)	O
,	O
CRP	B:C0201657
,	O
fecal	O
calprotectin	I:C1964053
and	O
CDAI	O
.	O

Consecutive	O
Crohn	O
's	I:C0010346
disease	I:C0010346
patients	O
with	O
quiescent	O
disease	O
underwent	O
meticulous	O
disease	I:C0012634
evaluation	O
with	O
MR	O
enterography	I:C4274338
(	O
MR	O
enterography	I:C4274338
)	O
,	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
(	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
)	O
,	O
CRP	O
,	O
fecal	B:C1964053
calprotectin	I:C1964053
and	O
CDAI	O
.	O

Consecutive	O
Crohn	O
's	I:C0010346
disease	I:C0010346
patients	O
with	O
quiescent	O
disease	O
underwent	O
meticulous	O
disease	I:C0012634
evaluation	O
with	O
MR	O
enterography	I:C4274338
(	O
MR	O
enterography	I:C4274338
)	O
,	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
(	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
)	O
,	O
CRP	O
,	O
fecal	O
calprotectin	I:C1964053
and	O
CDAI	B:C0451071
.	O

All	O
patients	O
were	O
tested	O
for	O
the	O
presence	O
of	O
Helicobacter	B:C0079488
pylori	I:C0079488
using	O
stool	O
antigen	O
detection	O
kit	O
.	O

Patients	O
infected	B:C0439663
with	O
Helicobacter	O
pylori	I:C0079488
were	O
offered	O
eradication	O
treatment	I:C0559761
with	O
sequential	O
therapy	O
.	O

Patients	O
infected	O
with	O
Helicobacter	B:C0079488
pylori	I:C0079488
were	O
offered	O
eradication	O
treatment	I:C0559761
with	O
sequential	O
therapy	O
.	O

Patients	O
infected	O
with	O
Helicobacter	O
pylori	I:C0079488
were	O
offered	O
eradication	B:C0559761
treatment	I:C0559761
with	O
sequential	O
therapy	O
.	O

Patients	O
infected	O
with	O
Helicobacter	O
pylori	I:C0079488
were	O
offered	O
eradication	O
treatment	I:C0559761
with	O
sequential	O
therapy	B:C0087111
.	O

Helicobacter	B:C0079488
pylori	I:C0079488
eradication	O
was	O
confirmed	O
using	O
urease	O
breath	I:C0695064
test	I:C0695064
and	O
stool	O
antigen	O
test	O
.	O

Helicobacter	O
pylori	I:C0079488
eradication	B:C3178994
was	O
confirmed	O
using	O
urease	O
breath	I:C0695064
test	I:C0695064
and	O
stool	O
antigen	O
test	O
.	O

Helicobacter	O
pylori	I:C0079488
eradication	O
was	O
confirmed	O
using	O
urease	B:C0695064
breath	I:C0695064
test	I:C0695064
and	O
stool	O
antigen	O
test	O
.	O

The	O
influence	O
of	O
Helicobacter	B:C0079488
pylori	I:C0079488
eradication	O
on	O
disease	O
activity	O
was	O
assessed	O
.	O

The	O
influence	O
of	O
Helicobacter	O
pylori	I:C0079488
eradication	B:C3178994
on	O
disease	O
activity	O
was	O
assessed	O
.	O

Out	O
of	O
56	O
patients	O
enrolled	O
,	O
six	O
patients	O
(	O
10.7	O
%	O
)	O
had	O
HP	B:C0079487
infection	I:C0079487
.	O

Of	O
them	O
,	O
five	O
patients	O
had	O
gastro-	B:C0267166
duodenitis	I:C0267166
per	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
.	O

Of	O
them	O
,	O
five	O
patients	O
had	O
gastro-	O
duodenitis	I:C0267166
per	O
video	B:C1721048
capsule	I:C1721048
endoscopy	I:C1721048
.	O

All	O
HP	B:C2748084
positive	I:C2748084
patients	O
were	O
offered	O
eradication	O
treatment	I:C0559761
and	O
underwent	O
successful	O
eradication	O
.	O

All	O
HP	O
positive	I:C2748084
patients	O
were	O
offered	O
eradication	B:C0559761
treatment	I:C0559761
and	O
underwent	O
successful	O
eradication	O
.	O

All	O
HP	O
positive	I:C2748084
patients	O
were	O
offered	O
eradication	O
treatment	I:C0559761
and	O
underwent	O
successful	O
eradication	B:C3178994
.	O

Notably	O
,	O
23	O
(	O
50	O
%	O
)	O
of	O
patients	O
had	O
proximal	B:C0205107
disease	O
per	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
,	O
most	O
of	O
them	O
(	O
78	O
%	O
)	O
were	O
HP	O
negative	O
.	O

Notably	O
,	O
23	O
(	O
50	O
%	O
)	O
of	O
patients	O
had	O
proximal	O
disease	B:C0012634
per	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
,	O
most	O
of	O
them	O
(	O
78	O
%	O
)	O
were	O
HP	O
negative	O
.	O

Notably	O
,	O
23	O
(	O
50	O
%	O
)	O
of	O
patients	O
had	O
proximal	O
disease	O
per	O
video	B:C1721048
capsule	I:C1721048
endoscopy	I:C1721048
,	O
most	O
of	O
them	O
(	O
78	O
%	O
)	O
were	O
HP	O
negative	O
.	O

CDAI	B:C0451071
,	O
CRP	O
,	O
fecal	O
calprotectin	I:C1964053
and	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
Lewis	O
inflammatory	I:C0243095
score	I:C0243095
did	O
not	O
change	O
significantly	O
following	O
Helicobacter	O
pylori	I:C0079488
eradication	O
,	O
Gastric	O
findings	I:C0455811
on	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
were	O
not	O
impacted	O
by	O
Helicobacter	O
pylori	I:C0079488
eradication	O
.	O

CDAI	O
,	O
CRP	B:C0201657
,	O
fecal	O
calprotectin	I:C1964053
and	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
Lewis	O
inflammatory	I:C0243095
score	I:C0243095
did	O
not	O
change	O
significantly	O
following	O
Helicobacter	O
pylori	I:C0079488
eradication	O
,	O
Gastric	O
findings	I:C0455811
on	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
were	O
not	O
impacted	O
by	O
Helicobacter	O
pylori	I:C0079488
eradication	O
.	O

CDAI	O
,	O
CRP	O
,	O
fecal	B:C1964053
calprotectin	I:C1964053
and	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
Lewis	O
inflammatory	I:C0243095
score	I:C0243095
did	O
not	O
change	O
significantly	O
following	O
Helicobacter	O
pylori	I:C0079488
eradication	O
,	O
Gastric	O
findings	I:C0455811
on	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
were	O
not	O
impacted	O
by	O
Helicobacter	O
pylori	I:C0079488
eradication	O
.	O

CDAI	O
,	O
CRP	O
,	O
fecal	O
calprotectin	I:C1964053
and	O
video	B:C1721048
capsule	I:C1721048
endoscopy	I:C1721048
Lewis	O
inflammatory	I:C0243095
score	I:C0243095
did	O
not	O
change	O
significantly	O
following	O
Helicobacter	O
pylori	I:C0079488
eradication	O
,	O
Gastric	O
findings	I:C0455811
on	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
were	O
not	O
impacted	O
by	O
Helicobacter	O
pylori	I:C0079488
eradication	O
.	O

CDAI	O
,	O
CRP	O
,	O
fecal	O
calprotectin	I:C1964053
and	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
Lewis	B:C0243095
inflammatory	I:C0243095
score	I:C0243095
did	O
not	O
change	O
significantly	O
following	O
Helicobacter	O
pylori	I:C0079488
eradication	O
,	O
Gastric	O
findings	I:C0455811
on	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
were	O
not	O
impacted	O
by	O
Helicobacter	O
pylori	I:C0079488
eradication	O
.	O

CDAI	O
,	O
CRP	O
,	O
fecal	O
calprotectin	I:C1964053
and	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
Lewis	O
inflammatory	I:C0243095
score	I:C0243095
did	O
not	O
change	O
significantly	O
following	O
Helicobacter	B:C0079488
pylori	I:C0079488
eradication	O
,	O
Gastric	O
findings	I:C0455811
on	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
were	O
not	O
impacted	O
by	O
Helicobacter	O
pylori	I:C0079488
eradication	O
.	O

CDAI	O
,	O
CRP	O
,	O
fecal	O
calprotectin	I:C1964053
and	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
Lewis	O
inflammatory	I:C0243095
score	I:C0243095
did	O
not	O
change	O
significantly	O
following	O
Helicobacter	O
pylori	I:C0079488
eradication	B:C3178994
,	O
Gastric	O
findings	I:C0455811
on	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
were	O
not	O
impacted	O
by	O
Helicobacter	O
pylori	I:C0079488
eradication	O
.	O

CDAI	O
,	O
CRP	O
,	O
fecal	O
calprotectin	I:C1964053
and	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
Lewis	O
inflammatory	I:C0243095
score	I:C0243095
did	O
not	O
change	O
significantly	O
following	O
Helicobacter	O
pylori	I:C0079488
eradication	O
,	O
Gastric	B:C0455811
findings	I:C0455811
on	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
were	O
not	O
impacted	O
by	O
Helicobacter	O
pylori	I:C0079488
eradication	O
.	O

CDAI	O
,	O
CRP	O
,	O
fecal	O
calprotectin	I:C1964053
and	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
Lewis	O
inflammatory	I:C0243095
score	I:C0243095
did	O
not	O
change	O
significantly	O
following	O
Helicobacter	O
pylori	I:C0079488
eradication	O
,	O
Gastric	O
findings	I:C0455811
on	O
video	B:C1721048
capsule	I:C1721048
endoscopy	I:C1721048
were	O
not	O
impacted	O
by	O
Helicobacter	O
pylori	I:C0079488
eradication	O
.	O

CDAI	O
,	O
CRP	O
,	O
fecal	O
calprotectin	I:C1964053
and	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
Lewis	O
inflammatory	I:C0243095
score	I:C0243095
did	O
not	O
change	O
significantly	O
following	O
Helicobacter	O
pylori	I:C0079488
eradication	O
,	O
Gastric	O
findings	I:C0455811
on	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
were	O
not	O
impacted	O
by	O
Helicobacter	B:C0079488
pylori	I:C0079488
eradication	O
.	O

CDAI	O
,	O
CRP	O
,	O
fecal	O
calprotectin	I:C1964053
and	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
Lewis	O
inflammatory	I:C0243095
score	I:C0243095
did	O
not	O
change	O
significantly	O
following	O
Helicobacter	O
pylori	I:C0079488
eradication	O
,	O
Gastric	O
findings	I:C0455811
on	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
were	O
not	O
impacted	O
by	O
Helicobacter	O
pylori	I:C0079488
eradication	B:C3178994
.	O

The	O
prevalence	O
of	O
Helicobacter	B:C0079488
pylori	I:C0079488
infection	O
in	O
patients	O
with	O
quiescent	O
CD	O
is	O
relatively	O
low	O
.	O

The	O
prevalence	O
of	O
Helicobacter	O
pylori	I:C0079488
infection	B:C0079487
in	O
patients	O
with	O
quiescent	O
CD	O
is	O
relatively	O
low	O
.	O

Eradication	B:C3178994
of	O
the	O
bacteria	O
did	O
not	O
significantly	O
change	O
neither	O
disease	O
activity	O
measures	O
nor	O
the	O
presence	O
of	O
gastro	O
-	I:C0267166
duodenitis	I:C0267166
per	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
,	O
suggesting	O
it	O
might	O
be	O
part	O
of	O
proximal	O
Crohn	O
's	I:C0010346
disease	I:C0010346
.	O

Eradication	O
of	O
the	O
bacteria	B:C0004611
did	O
not	O
significantly	O
change	O
neither	O
disease	O
activity	O
measures	O
nor	O
the	O
presence	O
of	O
gastro	O
-	I:C0267166
duodenitis	I:C0267166
per	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
,	O
suggesting	O
it	O
might	O
be	O
part	O
of	O
proximal	O
Crohn	O
's	I:C0010346
disease	I:C0010346
.	O

Eradication	O
of	O
the	O
bacteria	O
did	O
not	O
significantly	O
change	O
neither	O
disease	O
activity	O
measures	O
nor	O
the	O
presence	O
of	O
gastro	B:C0267166
-	I:C0267166
duodenitis	I:C0267166
per	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
,	O
suggesting	O
it	O
might	O
be	O
part	O
of	O
proximal	O
Crohn	O
's	I:C0010346
disease	I:C0010346
.	O

Eradication	O
of	O
the	O
bacteria	O
did	O
not	O
significantly	O
change	O
neither	O
disease	O
activity	O
measures	O
nor	O
the	O
presence	O
of	O
gastro	O
-	I:C0267166
duodenitis	I:C0267166
per	O
video	B:C1721048
capsule	I:C1721048
endoscopy	I:C1721048
,	O
suggesting	O
it	O
might	O
be	O
part	O
of	O
proximal	O
Crohn	O
's	I:C0010346
disease	I:C0010346
.	O

Eradication	O
of	O
the	O
bacteria	O
did	O
not	O
significantly	O
change	O
neither	O
disease	O
activity	O
measures	O
nor	O
the	O
presence	O
of	O
gastro	O
-	I:C0267166
duodenitis	I:C0267166
per	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
,	O
suggesting	O
it	O
might	O
be	O
part	O
of	O
proximal	B:C0205107
Crohn	O
's	I:C0010346
disease	I:C0010346
.	O

Eradication	O
of	O
the	O
bacteria	O
did	O
not	O
significantly	O
change	O
neither	O
disease	O
activity	O
measures	O
nor	O
the	O
presence	O
of	O
gastro	O
-	I:C0267166
duodenitis	I:C0267166
per	O
video	O
capsule	I:C1721048
endoscopy	I:C1721048
,	O
suggesting	O
it	O
might	O
be	O
part	O
of	O
proximal	O
Crohn	B:C0010346
's	I:C0010346
disease	I:C0010346
.	O

The	O
influence	O
of	O
Helicobacter	B:C0079488
pylori	I:C0079488
on	O
CD	O
activity	I:C0451071
merits	O
further	O
investigation	O
.	O

The	O
influence	O
of	O
Helicobacter	O
pylori	I:C0079488
on	O
CD	B:C0451071
activity	I:C0451071
merits	O
further	O
investigation	O
.	O

